使用多基因面板对威尔逊病的精确诊断:来自前性队列研究的见解
Jie Lin1,2,3, You-Liang Wang1,2,3, Yongqiang Qu1,3
1Department of Neurology, Fujian Institute of Neurology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Neurology. Genetics
|March 6, 2026
概括
一个新的下一代测序 (NGS) 面板通过检测多种ATP7B变体和区分副本来准确诊断威尔逊病 (WD). 这种全面的基因检测提高了威尔逊病的诊断产量,帮助早期干预.
科学领域:
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
- 神经遗传学 神经遗传学
背景情况:
- 威尔逊病 (WD) 是一种铜代谢的遗传性疾病.
- 对于WD的传统遗传诊断是有限的,可能导致诊断延迟.
- 下一代测序 (NGS) 为WD诊断提供了潜在的改善.
研究的目的:
- 评估定制NGS面板对威尔逊病的诊断效用.
- 为了识别新的ATP7B变异,并评估其他铜代谢基因的作用.
- 为了区分WD与光谱条件.
主要方法:
- 一项针对144名怀疑患有WD的个人进行的前性队列研究.
- 针对ATP7B基因和10个相关基因的NGS面板测序.
- 变异过,注释,分类和验证测试 (桑格,MLPA,RT-PCR).
主要成果:
- 该NGS小组实现了90%的诊断确认率 (129/144名患者).
- 确定了10种新的ATP7B变体,包括内基变体和副本数变体.
- 通过其他铜代谢基因的变异解决了六例病例,并重新分类了一份副本.
结论:
- 一个全面的多基因NGS面板为WD提供了精确的诊断.
- 这个面板可以检测经典的,非常规的变体,并区分副本.
- 使用该面板进行早期遗传测试可以提高诊断准确度,并指导及时干预.
相关概念视频
Genome-wide Association Studies-GWAS
12.9K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.9K
Pharmacogenomics: Identification of New Drug Targets
129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129


